Stock screener

PMCB

Conviction 0HealthcareScan · Thu, Jun 25, 2026
PMCB$0.7521-2.07%
ResistanceSupportVol 14
63 bars
Vol MA14 125.51K
Mar 26Apr 14May 1May 19Jun 8Jun 25
PharmaCyte Biotech, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)pharmacyte.com
Price0.7521
Change-2.07%
Gap-0.91%
Rel volume0.28×
Avg volume133.81K
Avg $ vol103.11K
SMA 200.7607
SMA 500.7650
SMA 2000.8234
Price vs 50-1.69%
Price vs 200-8.65%
MA stackbearish
50/200 cross
Supertrendup · 0.6341
RSI (14)49
MACD hist0.00
MACD crossbull · 7d
Stoch %K / %D49 / 57
ADX (14)12
+DI / −DI19 / 17
RSI divergence
MACD divergence
ATR %+7.82%
ADR %6.98%
52w high1.22
52w low0.6300
From 52w high-38.35%
Above 52w low+19.38%
New 52w highNo
SqueezeOff
Bollinger width24.56%
%B0.45
Donchian pos41.86%
Donchian high0.8700
Donchian low0.6672
AVWAP (52w high)1.01
vs AVWAP high-25.88%
AVWAP (52w low)1.08
vs AVWAP low-30.05%
OBV trendFlat
Chaikin MF (20)-0.06
Today vs 20d0.28×
Avg vol (14d)125.51K
Avg vol (20d)133.81K
Avg $ vol (20d)103.11K
Market cap8.07M
RS 3m (vs SPY)-13.80%
RS 6m (vs SPY)-18.18%
RS line new highNo
Trend template0/8
Technical rank32.6
1 week-4.46%
1 month-4.26%
3 months-1.17%
6 months-10.34%
1 year-29.05%
YTD+1.91%
P/E0.26
P/B0.21
P/S
P/FCF
EPS3.19
Div yield
ROE80.43%
ROA54.87%
Debt/Eq0.06
Current12.33
EV/EBITDA2.20
Gross margin
Net margin
Rev growth
EPS growth
Price target
Target upside
Analyst rating
Institutional
Ent. value-9.63M
Revenue0
Net income746.86K
Gross profit0
Free cash flow
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out10.74M
Employees2
ListedThu, Sep 11, 2003
Free float9.48M
Float %88.3%
Short interest376.38K
Days to cover1.5d
Short volume19.4%
Squeeze score16 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction0 / 100
Pattern quality
Tech rank32.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance0.9200
Support0.6685
Days since event
Candle confirm
News sentiment

Financials as of Sat, Jan 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PMCB

All disclosures →
No recent disclosed trades by Congress in PMCB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PMCB

No recent insider (Form 4) filings in PMCB. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in PMCB

EDGAR →

No recent SEC filings on file for PMCB.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.